Feature | February 27, 2013

Oncology Information Systems' Reporting and Alerts Leave Providers Wanting More

As meaningful use and ACOs pick up steam, oncology providers contend with regulatory pressures with or without help from their vendors

Oncology Information Management Systems KLAS Meaningful Use Reports Alert

February 27, 2013 — Alerts and reporting are two of the most challenging aspects of medical oncology, in addition to being the tools providers are least happy with overall. This is according to a new report from KLAS titled Oncology 2012: Pulling the Curtain Back.

Study findings reveal that oncology information system vendors struggle with alerts. Specifically, Epic, Varian and Elekta seem to perform below average. Reporting is also an area for improvement. Providers report that Varian and Elekta's canned reports are not robust enough to meet their needs, and the customized reports are difficult to use. Epic's customized reports are not as user friendly as providers would like them to be.

Meaningful use (MU) is another hot button for providers. The vast majority of oncology providers interviewed indicate that they are planning to attest for MU, but according to the report, vendors differ in their ability to partner with providers in that effort. Altos and BMSi are the best reported MU partners because they are more hands on and appear to be more focused on customer needs.

Though Varian is one of the dominant players in the oncology IT market, the report indicates that they are not the best MU partner. The MU version of Varian ARIA did not come out on the promised timeline, and some providers report that Varian seems out of touch with customers. Additionally, Epic is identified as a vendor that could improve due to the fact that the system is not designed for all the needs of oncology providers.

With MU Stage 2 bearing down, patient portals are also identified as an important consideration for oncology providers. Only 30 percent of those surveyed said they are currently using a patient portal, and many still need to make that decision.

"Most of the Epic and Altos customers in the study said they are using patient portals; however, we spoke with only a small number of those customers," said Monique Rasband, oncology research director and author of the report. "The majority of Elekta and Varian customers have not yet adopted a portal. Most Varian and Elekta customers said they are looking to their current oncology IT vendor to supply a portal, in spite of most portals being rudimentary at this point."

This study includes ratings on medical and radiation oncology IS vendors. Vendors rated in radiation oncology are BMSi, Elekta and Varian. Vendors rated in medical oncology are Altos (early data), Elekta, Epic, IntrinsiQ and Varian. To learn more about the oncology IS market and the vendors in this study, providers and vendors can review the full report Oncology IT: Pulling the Curtain Back. This report is available to healthcare providers at a significant discount.

For more information: www.KLASresearch.com/KLASreports

Related Content

IBA, Philips, Ambient Experience, proton therapy, Proteus One, Proteus Plus, ASTRO 2016
News | Radiation Therapy | October 19, 2016
IBA (Ion Beam Applications SA) and Philips announced in September the launch of a dedicated patient-centric Ambient...
stereotactic radiosurgery, EGFR-mutant non-small cell lung cancer, NSCLC, brain metastases, Yale Cancer Center analysis, ASTRO 2016
News | Radiation Therapy | October 19, 2016
A Yale Cancer Center team completed a multi-institutional analysis of treatment options for patients with newly...
intensity modulated radiation therapy outcomes, IMRT, head and neck cancers, facility volume, ASTRO 2016
News | Radiation Therapy | October 18, 2016
The association between provider case volume and outcomes has long been suggested in cancer care. A Yale Cancer Center...
Technology | Radiation Therapy | October 18, 2016
Elekta introduced the Leksell Vantage Stereotactic System, its latest system for very precise neurosurgery, at the...
RaySearch Laboratories, RayStation 6, RayCare oncology information system, OIS, treatment planning, radiation therapy, ASTRO 2016
News | Radiation Therapy | October 18, 2016
RaySearch demonstrated new features in the upcoming release of its proprietary treatment planning system, RayStation,...
Agfa Healthcare, Enterprise Imaging, RSNA 2016, new version, patient-centric care
Technology | Enterprise Imaging | October 18, 2016
October 18, 2016 — Agfa HealthCare announced today that it is releasing a new version of its...
Technology | Radiation Therapy | October 13, 2016
At the 58th annual meeting of the American Society for Radiation Oncology (ASTRO), Orfit Industries presented the new...
Philips, RSNA 2016, IQon spectral CT

IQon Spectral CT image courtesy of Philips Healthcare

News | Information Technology | October 13, 2016
October 13, 2016 — Philips announced that it will be displaying a variety of solutions aimed at increasing diagnostic
pediatric medulloblastoma, brain tumor, radiation therapy, boost volume, clinical study, ASTRO 2016
News | Radiation Therapy | October 13, 2016
In the largest trial conducted for average risk (A-R) medulloblastoma, survival rates following reduced radiation...
Novalis Circle Symposium, stereotactic radiosurgery, SRS, spine bone metastasis, ASTRO 2016

The Novalis Circle symposium at the ASTRO Annual Meeting focused on stereotactic radiosurgery for patients with spine bone metastasis (Photo: Business Wire)

News | Radiation Therapy | October 11, 2016
The Novalis Circle hosted a symposium at this year’s American Society for Radiation Oncology (ASTRO) Annual Meeting to...
Overlay Init